SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021448
Filing Date
2023-05-12
Accepted
2023-05-11 19:37:17
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20230331.htm   iXBRL 10-Q 1462284
2 EX-31.1 cycn-ex31_1.htm EX-31.1 14935
3 EX-31.2 cycn-ex31_2.htm EX-31.2 14943
4 EX-32.1 cycn-ex32_1.htm EX-32.1 8556
5 EX-32.2 cycn-ex32_2.htm EX-32.2 8564
  Complete submission text file 0000950170-23-021448.txt   6034122

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycn-20230331_cal.xml EX-101.CAL 31600
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycn-20230331_def.xml EX-101.DEF 198724
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20230331.xsd EX-101.SCH 47784
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cycn-20230331_lab.xml EX-101.LAB 414808
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20230331_pre.xml EX-101.PRE 297596
55 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20230331_htm.xml XML 1010771
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 23912748
SIC: 2834 Pharmaceutical Preparations